Table of Contents for the Digital Edition of Pharmaceutical Technology - October 2009 Pharmaceutical Technology - October 2009 Table of Contents Looking Ahead PhRMA’s Stake in Reform Sneaky and Suspicious In the Field In the Spotlight New Leadership Seeks to Transform FDA Getting the Truth out of Dissolution Testing The Emerging Markets of the East Delivering Results in Nanotechnology Formulation and Evaluation of Famotidine Floating Matrix Tablets Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer The Case for Supplier Qualification Critical Challenges to Implementing QbD: A Q&A with FDA Global Regulatory Submissions for QbD: Wyeth’s Experience Equivalence by Design for Advanced Dosage Forms and Drug Products The Relevance of Continuous Solid Oral Dosage Processing and NIR Spectroscopy in Meeting the Needs of QbD and PAT Pharmaceutical Quality by Design for Generic Drugs Square Root of (N) + 1 Sampling Plan Characterization of Heparin Products Sizing Up the CDMO Market Advertorial Profiles Pharma Capsules Industry Pipeline Product and Services Showcase/Marketplace Career Opportunities Ad Index Progress Made on the Path to Biosimilars Pharmaceutical Technology - October 2009 Pharmaceutical Technology - October 2009 - Pharmaceutical Technology - October 2009 (Page Cover1) Pharmaceutical Technology - October 2009 - Pharmaceutical Technology - October 2009 (Page Cover2) Pharmaceutical Technology - October 2009 - Pharmaceutical Technology - October 2009 (Page 3) Pharmaceutical Technology - October 2009 - Pharmaceutical Technology - October 2009 (Page 4) Pharmaceutical Technology - October 2009 - Pharmaceutical Technology - October 2009 (Page 5) Pharmaceutical Technology - October 2009 - Pharmaceutical Technology - October 2009 (Page 6) Pharmaceutical Technology - October 2009 - Pharmaceutical Technology - October 2009 (Page 7) Pharmaceutical Technology - October 2009 - Table of Contents (Page 8) Pharmaceutical Technology - October 2009 - Table of Contents (Page 9) Pharmaceutical Technology - October 2009 - Table of Contents (Page 10) Pharmaceutical Technology - October 2009 - Table of Contents (Page 11) Pharmaceutical Technology - October 2009 - Looking Ahead (Page 12) Pharmaceutical Technology - October 2009 - Looking Ahead (Page 13) Pharmaceutical Technology - October 2009 - PhRMA’s Stake in Reform (Page 14) Pharmaceutical Technology - October 2009 - PhRMA’s Stake in Reform (Page 15) Pharmaceutical Technology - October 2009 - Sneaky and Suspicious (Page 16) Pharmaceutical Technology - October 2009 - Sneaky and Suspicious (Page 17) Pharmaceutical Technology - October 2009 - In the Field (Page 18) Pharmaceutical Technology - October 2009 - In the Field (Page 19) Pharmaceutical Technology - October 2009 - In the Field (Page 20) Pharmaceutical Technology - October 2009 - In the Field (Page 21) Pharmaceutical Technology - October 2009 - In the Field (Page 22) Pharmaceutical Technology - October 2009 - In the Field (Page 23) Pharmaceutical Technology - October 2009 - In the Field (Page 24) Pharmaceutical Technology - October 2009 - In the Field (Page 25) Pharmaceutical Technology - October 2009 - In the Field (Page 26) Pharmaceutical Technology - October 2009 - In the Field (Page 27) Pharmaceutical Technology - October 2009 - In the Field (Page 28) Pharmaceutical Technology - October 2009 - In the Field (Page 29) Pharmaceutical Technology - October 2009 - In the Spotlight (Page 30) Pharmaceutical Technology - October 2009 - In the Spotlight (Page 31) Pharmaceutical Technology - October 2009 - New Leadership Seeks to Transform FDA (Page 32) Pharmaceutical Technology - October 2009 - New Leadership Seeks to Transform FDA (Page 33) Pharmaceutical Technology - October 2009 - New Leadership Seeks to Transform FDA (Page 34) Pharmaceutical Technology - October 2009 - New Leadership Seeks to Transform FDA (Page 35) Pharmaceutical Technology - October 2009 - New Leadership Seeks to Transform FDA (Page 36) Pharmaceutical Technology - October 2009 - New Leadership Seeks to Transform FDA (Page 37) Pharmaceutical Technology - October 2009 - New Leadership Seeks to Transform FDA (Page 38) Pharmaceutical Technology - October 2009 - New Leadership Seeks to Transform FDA (Page 39) Pharmaceutical Technology - October 2009 - New Leadership Seeks to Transform FDA (Page 40) Pharmaceutical Technology - October 2009 - New Leadership Seeks to Transform FDA (Page 41) Pharmaceutical Technology - October 2009 - Getting the Truth out of Dissolution Testing (Page 42) Pharmaceutical Technology - October 2009 - Getting the Truth out of Dissolution Testing (Page 43) Pharmaceutical Technology - October 2009 - Getting the Truth out of Dissolution Testing (Page 44) Pharmaceutical Technology - October 2009 - Getting the Truth out of Dissolution Testing (Page 45) Pharmaceutical Technology - October 2009 - Getting the Truth out of Dissolution Testing (Page 46) Pharmaceutical Technology - October 2009 - Getting the Truth out of Dissolution Testing (Page 47) Pharmaceutical Technology - October 2009 - Getting the Truth out of Dissolution Testing (Page 48) Pharmaceutical Technology - October 2009 - Getting the Truth out of Dissolution Testing (Page 49) Pharmaceutical Technology - October 2009 - The Emerging Markets of the East (Page 50) Pharmaceutical Technology - October 2009 - The Emerging Markets of the East (Page 51) Pharmaceutical Technology - October 2009 - The Emerging Markets of the East (Page 52) Pharmaceutical Technology - October 2009 - The Emerging Markets of the East (Page 53) Pharmaceutical Technology - October 2009 - Delivering Results in Nanotechnology (Page 54) Pharmaceutical Technology - October 2009 - Delivering Results in Nanotechnology (Page 55) Pharmaceutical Technology - October 2009 - Delivering Results in Nanotechnology (Page 56) Pharmaceutical Technology - October 2009 - Delivering Results in Nanotechnology (Page 57) Pharmaceutical Technology - October 2009 - Delivering Results in Nanotechnology (Page 58) Pharmaceutical Technology - October 2009 - Delivering Results in Nanotechnology (Page 59) Pharmaceutical Technology - October 2009 - Formulation and Evaluation of Famotidine Floating Matrix Tablets (Page 60) Pharmaceutical Technology - October 2009 - Formulation and Evaluation of Famotidine Floating Matrix Tablets (Page 61) Pharmaceutical Technology - October 2009 - Formulation and Evaluation of Famotidine Floating Matrix Tablets (Page 62) Pharmaceutical Technology - October 2009 - Formulation and Evaluation of Famotidine Floating Matrix Tablets (Page 63) Pharmaceutical Technology - October 2009 - Formulation and Evaluation of Famotidine Floating Matrix Tablets (Page 64) Pharmaceutical Technology - October 2009 - Formulation and Evaluation of Famotidine Floating Matrix Tablets (Page 65) Pharmaceutical Technology - October 2009 - Formulation and Evaluation of Famotidine Floating Matrix Tablets (Page 66) Pharmaceutical Technology - October 2009 - Formulation and Evaluation of Famotidine Floating Matrix Tablets (Page 67) Pharmaceutical Technology - October 2009 - Formulation and Evaluation of Famotidine Floating Matrix Tablets (Page 68) Pharmaceutical Technology - October 2009 - Formulation and Evaluation of Famotidine Floating Matrix Tablets (Page 69) Pharmaceutical Technology - October 2009 - Formulation and Evaluation of Famotidine Floating Matrix Tablets (Page 70) Pharmaceutical Technology - October 2009 - Formulation and Evaluation of Famotidine Floating Matrix Tablets (Page 71) Pharmaceutical Technology - October 2009 - Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer (Page 72) Pharmaceutical Technology - October 2009 - Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer (Page 73) Pharmaceutical Technology - October 2009 - Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer (Page 74) Pharmaceutical Technology - October 2009 - Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer (Page 75) Pharmaceutical Technology - October 2009 - Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer (Page 76) Pharmaceutical Technology - October 2009 - Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer (Page 77) Pharmaceutical Technology - October 2009 - Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer (Page 78) Pharmaceutical Technology - October 2009 - Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer (Page 79) Pharmaceutical Technology - October 2009 - Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer (Page 80) Pharmaceutical Technology - October 2009 - Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer (Page 81) Pharmaceutical Technology - October 2009 - Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer (Page 82) Pharmaceutical Technology - October 2009 - Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer (Page 83) Pharmaceutical Technology - October 2009 - The Case for Supplier Qualification (Page 84) Pharmaceutical Technology - October 2009 - The Case for Supplier Qualification (Page 85) Pharmaceutical Technology - October 2009 - The Case for Supplier Qualification (Page 86) Pharmaceutical Technology - October 2009 - The Case for Supplier Qualification (Page 87) Pharmaceutical Technology - October 2009 - The Case for Supplier Qualification (Page 88) Pharmaceutical Technology - October 2009 - The Case for Supplier Qualification (Page 89) Pharmaceutical Technology - October 2009 - Critical Challenges to Implementing QbD: A Q&A with FDA (Page 90) Pharmaceutical Technology - October 2009 - Critical Challenges to Implementing QbD: A Q&A with FDA (Page 91) Pharmaceutical Technology - October 2009 - Critical Challenges to Implementing QbD: A Q&A with FDA (Page 92) Pharmaceutical Technology - October 2009 - Critical Challenges to Implementing QbD: A Q&A with FDA (Page 93) Pharmaceutical Technology - October 2009 - Critical Challenges to Implementing QbD: A Q&A with FDA (Page 94) Pharmaceutical Technology - October 2009 - Critical Challenges to Implementing QbD: A Q&A with FDA (Page 95) Pharmaceutical Technology - October 2009 - Global Regulatory Submissions for QbD: Wyeth’s Experience (Page 96) Pharmaceutical Technology - October 2009 - Global Regulatory Submissions for QbD: Wyeth’s Experience (Page 97) Pharmaceutical Technology - October 2009 - Global Regulatory Submissions for QbD: Wyeth’s Experience (Page 98) Pharmaceutical Technology - October 2009 - Global Regulatory Submissions for QbD: Wyeth’s Experience (Page 99) Pharmaceutical Technology - October 2009 - Global Regulatory Submissions for QbD: Wyeth’s Experience (Page 100) Pharmaceutical Technology - October 2009 - Global Regulatory Submissions for QbD: Wyeth’s Experience (Page 101) Pharmaceutical Technology - October 2009 - Global Regulatory Submissions for QbD: Wyeth’s Experience (Page 102) Pharmaceutical Technology - October 2009 - Global Regulatory Submissions for QbD: Wyeth’s Experience (Page 103) Pharmaceutical Technology - October 2009 - Equivalence by Design for Advanced Dosage Forms and Drug Products (Page 104) Pharmaceutical Technology - October 2009 - Equivalence by Design for Advanced Dosage Forms and Drug Products (Page 105) Pharmaceutical Technology - October 2009 - Equivalence by Design for Advanced Dosage Forms and Drug Products (Page 106) Pharmaceutical Technology - October 2009 - Equivalence by Design for Advanced Dosage Forms and Drug Products (Page 107) Pharmaceutical Technology - October 2009 - Equivalence by Design for Advanced Dosage Forms and Drug Products (Page 108) Pharmaceutical Technology - October 2009 - Equivalence by Design for Advanced Dosage Forms and Drug Products (Page 109) Pharmaceutical Technology - October 2009 - Equivalence by Design for Advanced Dosage Forms and Drug Products (Page 110) Pharmaceutical Technology - October 2009 - Equivalence by Design for Advanced Dosage Forms and Drug Products (Page 111) Pharmaceutical Technology - October 2009 - The Relevance of Continuous Solid Oral Dosage Processing and NIR Spectroscopy in Meeting the Needs of QbD and PAT (Page 112) Pharmaceutical Technology - October 2009 - The Relevance of Continuous Solid Oral Dosage Processing and NIR Spectroscopy in Meeting the Needs of QbD and PAT (Page 113) Pharmaceutical Technology - October 2009 - The Relevance of Continuous Solid Oral Dosage Processing and NIR Spectroscopy in Meeting the Needs of QbD and PAT (Page 114) Pharmaceutical Technology - October 2009 - The Relevance of Continuous Solid Oral Dosage Processing and NIR Spectroscopy in Meeting the Needs of QbD and PAT (Page 115) Pharmaceutical Technology - October 2009 - The Relevance of Continuous Solid Oral Dosage Processing and NIR Spectroscopy in Meeting the Needs of QbD and PAT (Page 116) Pharmaceutical Technology - October 2009 - The Relevance of Continuous Solid Oral Dosage Processing and NIR Spectroscopy in Meeting the Needs of QbD and PAT (Page 117) Pharmaceutical Technology - October 2009 - The Relevance of Continuous Solid Oral Dosage Processing and NIR Spectroscopy in Meeting the Needs of QbD and PAT (Page 118) Pharmaceutical Technology - October 2009 - The Relevance of Continuous Solid Oral Dosage Processing and NIR Spectroscopy in Meeting the Needs of QbD and PAT (Page 119) Pharmaceutical Technology - October 2009 - The Relevance of Continuous Solid Oral Dosage Processing and NIR Spectroscopy in Meeting the Needs of QbD and PAT (Page 120) Pharmaceutical Technology - October 2009 - The Relevance of Continuous Solid Oral Dosage Processing and NIR Spectroscopy in Meeting the Needs of QbD and PAT (Page 121) Pharmaceutical Technology - October 2009 - Pharmaceutical Quality by Design for Generic Drugs (Page 122) Pharmaceutical Technology - October 2009 - Pharmaceutical Quality by Design for Generic Drugs (Page 123) Pharmaceutical Technology - October 2009 - Pharmaceutical Quality by Design for Generic Drugs (Page 124) Pharmaceutical Technology - October 2009 - Pharmaceutical Quality by Design for Generic Drugs (Page 125) Pharmaceutical Technology - October 2009 - Pharmaceutical Quality by Design for Generic Drugs (Page 126) Pharmaceutical Technology - October 2009 - Pharmaceutical Quality by Design for Generic Drugs (Page 127) Pharmaceutical Technology - October 2009 - Square Root of (N) + 1 Sampling Plan (Page 128) Pharmaceutical Technology - October 2009 - Square Root of (N) + 1 Sampling Plan (Page 129) Pharmaceutical Technology - October 2009 - Characterization of Heparin Products (Page 130) Pharmaceutical Technology - October 2009 - Characterization of Heparin Products (Page 131) Pharmaceutical Technology - October 2009 - Sizing Up the CDMO Market (Page 132) Pharmaceutical Technology - October 2009 - Sizing Up the CDMO Market (Page 133) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 134) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 135) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 136) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 137) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 138) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 139) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 140) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 141) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 142) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 143) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 144) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 145) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 146) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 147) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 148) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 149) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 150) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 151) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 152) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 153) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 154) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 155) Pharmaceutical Technology - October 2009 - Advertorial Profiles (Page 156) Pharmaceutical Technology - October 2009 - Pharma Capsules (Page 157) Pharmaceutical Technology - October 2009 - Industry Pipeline (Page 158) Pharmaceutical Technology - October 2009 - Industry Pipeline (Page 159) Pharmaceutical Technology - October 2009 - Industry Pipeline (Page 160) Pharmaceutical Technology - October 2009 - Industry Pipeline (Page 161) Pharmaceutical Technology - October 2009 - Industry Pipeline (Page 162) Pharmaceutical Technology - October 2009 - Industry Pipeline (Page 163) Pharmaceutical Technology - October 2009 - Industry Pipeline (Page 164) Pharmaceutical Technology - October 2009 - Product and Services Showcase/Marketplace (Page 165) Pharmaceutical Technology - October 2009 - Product and Services Showcase/Marketplace (Page 166) Pharmaceutical Technology - October 2009 - Product and Services Showcase/Marketplace (Page 167) Pharmaceutical Technology - October 2009 - Career Opportunities (Page 168) Pharmaceutical Technology - October 2009 - Ad Index (Page 169) Pharmaceutical Technology - October 2009 - Progress Made on the Path to Biosimilars (Page 170) Pharmaceutical Technology - October 2009 - Progress Made on the Path to Biosimilars (Page Cover3) Pharmaceutical Technology - October 2009 - Progress Made on the Path to Biosimilars (Page Cover4) http://digital.findpharma.com/nxtbooks/advanstar/pt_201202 http://digital.findpharma.com/nxtbooks/advanstar/pt_201201 http://digital.findpharma.com/nxtbooks/advanstar/pt_201112 http://digital.findpharma.com/nxtbooks/advanstar/pt_201111 http://digital.findpharma.com/nxtbooks/advanstar/pt_201111_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201110 http://digital.findpharma.com/nxtbooks/advanstar/pt_201109 http://digital.findpharma.com/nxtbooks/advanstar/pt_201109_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201108 http://digital.findpharma.com/nxtbooks/advanstar/pt_201108_supplmnt http://digital.findpharma.com/nxtbooks/advanstar/pt_201107 http://digital.findpharma.com/nxtbooks/advanstar/pt_201106 http://digital.findpharma.com/nxtbooks/advanstar/pt_201105_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201105 http://digital.findpharma.com/nxtbooks/advanstar/pt_201104 http://digital.findpharma.com/nxtbooks/advanstar/pt_201104_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201103 http://digital.findpharma.com/nxtbooks/advanstar/pt_201102 http://digital.findpharma.com/nxtbooks/advanstar/pt_201101 http://digital.findpharma.com/nxtbooks/advanstar/pt_201012 http://digital.findpharma.com/nxtbooks/advanstar/pt_201011 http://digital.findpharma.com/nxtbooks/advanstar/pt_201010 http://digital.findpharma.com/nxtbooks/advanstar/pt_201009 http://digital.findpharma.com/nxtbooks/advanstar/pt_201008 http://digital.findpharma.com/nxtbooks/advanstar/pt_201007 http://digital.findpharma.com/nxtbooks/advanstar/pt_201006 http://digital.findpharma.com/nxtbooks/advanstar/pt_201005 http://digital.findpharma.com/nxtbooks/advanstar/pt_201004 http://digital.findpharma.com/nxtbooks/advanstar/pt_201003 http://digital.findpharma.com/nxtbooks/advanstar/pt201002 http://digital.findpharma.com/nxtbooks/advanstar/pt_201001 http://digital.findpharma.com/nxtbooks/advanstar/pt_200912 http://digital.findpharma.com/nxtbooks/advanstar/pt_200911 http://digital.findpharma.com/nxtbooks/advanstar/pt10_2009 http://digital.findpharma.com/nxtbooks/advanstar/pt_200909 http://digital.findpharma.com/nxtbooks/advanstar/pt_200908 http://digital.findpharma.com/nxtbooks/advanstar/pt_200907 http://digital.findpharma.com/nxtbooks/advanstar/pt_200906 http://digital.findpharma.com/nxtbooks/advanstar/pt_200905 http://www.nxtbook.com/nxtbooks/advanstar/pt_200904 http://www.nxtbook.com/nxtbooks/advanstar/pt_200903 http://www.nxtbook.com/nxtbooks/advanstar/pt_200902 http://www.nxtbook.com/nxtbooks/advanstar/pt_200901 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.